Targeted Therapies in Oncology
November 2015
Volume: 4
Issue: 8
October 2015
Volume: 4
Issue: 7
September 2015
Volume: 4
Issue: 6
July 2015
Volume: 4
Issue: 5
May 2015
Volume: 4
Issue: 4
April 2015
Volume: 4
Issue: 2
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
3
Pelareorep Offers Promise in Second-Line KRAS-Mutant Metastatic CRC
4
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
5